Drugs / Xenaderm
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00645164 | Mar → May 2008 | — | Healthpoint | Completed | No outcome recorded |
| Phase 1 | NCT00644917 | Feb 2008 | — | Healthpoint | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00714519 | Jul → Oct 2008 | — | Healthpoint | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xenaderm | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00644917 ↗ |
| Route | Topical | “Topical, BID or as needed” NCT00714519 ↗ |